RxDoctor Payments Data

Patricio Escalona

Psychiatry · Albuquerque, NMNPI 1073626156

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $402,210 of the $486,639 with a category attached, or 82.7%. Alkermes, Inc. accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest. Among psychiatry clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$486,639in general payments, 2019–2025

Across 463 payments — averaging $1051.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$486K
  • Teva Pharmaceuticals USA, Inc.$523

What the payments were for

  • Consulting fees$23,5905%
  • Speaking & faculty fees$402,21083%
  • Travel & lodging$47,96810%
  • Food & beverage$12,8703%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alkermes, Inc.461$486,116
Teva Pharmaceuticals USA, Inc.2$523

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$486,639 in reported general payments places this provider in the 95th percentile of 174 psychiatry providers in New Mexico.

See all psychiatry providers in New Mexico →

Other psychiatry in Albuquerque

See the full list for New Mexico →

Where these figures come from

Is this you, or does something look wrong? →